Isotope choice and the effect of edema on prostate brachytherapy dosimetry

Citation
Wm. Butler et al., Isotope choice and the effect of edema on prostate brachytherapy dosimetry, MED PHYS, 27(5), 2000, pp. 1067-1075
Citations number
25
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
Journal title
MEDICAL PHYSICS
ISSN journal
00942405 → ACNP
Volume
27
Issue
5
Year of publication
2000
Pages
1067 - 1075
Database
ISI
SICI code
0094-2405(200005)27:5<1067:ICATEO>2.0.ZU;2-M
Abstract
In prostate brachytherapy, post implant dosimetry quality parameters may be strongly affected by edema brought on by the trauma of the implant procedu re since the amount of edema and the time course of its resolution are high ly variable from patient to patient. Edema was simulated from preplans on t hree prostates which had ultrasound prostate volumes of 18.7, 40.7 and 60.2 cm(3) expanded to planning volumes of 32.9, 60.0 and 87.8 cm(3), respectiv ely. The preplans were designed so that identical seed distributions for a given prostate gave virtually identical target dose coverage of 99.7 +/- 0. 3% of the planning volume when using either I-125 Or Pd-103. Simulated CT e dema volume expansions of 0%, 10%, 20% and 30% were imposed anisotropically in accordance with clinical observations so that the expansion in the supe rior-inferior direction was twice that of the transverse dimensions. Dose-v olume histograms (DVHs) were analyzed for each prostate as a function of is otope and degree of edema. The Pd-103 implants were more greatly affected b y fixed amounts of edema than I-125 implants, and the slopes of the DVH cur ves indicate less homogeneity from Pd-103 implants. The DVHs were then weig hted according to the portion of the isotope decay curve occupied by each e dema step for half-lives of edema resolution of 5, 10 and 20 days which are within the range of clinically observed resolution times. The weighted DVH s were summed to give a net DVH. corresponding to the overall dynamic effec t of edema. A greater fraction of the defined prostate volume received dose s in the range of likely therapeutic significance, from 75% to 125% of the prescribed minimal peripheral dose (mPD), from I-125 implants than from Pd- 103 implants. These differences in dosimetric quality arise from two differ ences in the physical properties of the isotopes: more rapid attenuation of Pd-103 photons with distance creates cool spots in an edematous prostate, and the shorter half-life of Pd-103 causes a greater fraction of the isotop e decay to consist of the prostate in an edematous state. An increase in Pd -103 seed strength by about 10% beyond that required to achieve equal cover age with an identical seed distribution using I-125 should minimize the dif ferences brought on by edema. (C) 2000 American Association of Physicists i n Medicine. [S0094-2405(00)01505-4].